The World Health Organization had suspended clinical trial programs using hydroxychloroquine following the initial report, as did the U.K. and France. The Lancet’s peer-reviewed study, published on May 22, claimed to have analyzed Surgisphere data collected from almost 96,000 Covid-19 patients across the globe. But in the days after publication, concerns over the underlying data bubbled up. … Continue reading The Tiny Data Firm at the Center of the Hydroxychloroquine Storm – Bloomberg